Skip to Content

'
David S Hong, M.D.

Present Title & Affiliation

Primary Appointment

Deputy Chair, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Research Interests

  • Phase I studies
  • Drug development
  • The molecular basis of cancer  

Click here for the most up-to-date list of Dr. Hong's publications.

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd
Unit Number: 455
Houston, TX 77030
Room Number: FC8.3050
Phone: 713.563.5844
Fax: 713.563.0566

Education & Training

Degree-Granting Education

1999 Albert Einstein College of Medicine, Bronx, NY, MD
1993 Yale University, New Haven, CT, BS

Postgraduate Training

9/2004-10/2004 Rotation, NCI-CTEP, Bethesda, MD
6/2004-6/2005 Chief Medical Oncology Fellow, The University of Texas MD Anderson Cancer Center, Houston, TX, Robert A. Wolff, M.D.
6/2002-6/2005 Clinical Fellowship, Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Robert A. Wolff, M.D.
6/1999-1/2001 Clinical Residency, Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, Thomas Kane, M.D.

Board Certifications

11/2007 Medical Oncology
11/2002 Internal Medicine

Grant & Contract Support

Title: Targeted Therapy Program Cancer Center Support (Core) Grant
Funding Source: NIH/NCI
Role: Co-Program Leader
Principal Investigator: Ronald DePinho
Duration: 7/1/1978 - 6/30/2013

Last updated: 7/19/2013